Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate long-term safety, tolerability and efficacy for AFQ056 in patients
who have completed an AFQ056A study in Parkinson's disease L-dopa induced dyskinesias
(PD-LID).